Anchyra Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.28M Buy
4,885
+42
+0.9% +$11.1K 0.27% 67
2026
Q2
$1.07M Sell
4,843
-210
-4% -$58.1K 0.26% 78
2026
Q1
$1.49M Buy
5,053
+73
+1% +$21.7K 0.45% 45
2025
Q4
$1.36M Buy
+4,980
New +$1.35M 0.42% 47

Other funds holding CME

Anchyra Partners's CME Position: Q3 2026 in Review

Anchyra Partners increased its CME Group (CME) stake by 0.87% in Q3 2026, buying an estimated $11.1K and bringing the position to 4,885 shares worth $1.28M. The position accounts for 0.27% of the portfolio, ranked #67.

Anchyra Partners first reported a position in CME in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.49M in Q1 2026. 1,289 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Anchyra Partners held 4,885 shares of CME Group worth $1.28M as of Q3 2026.
  • Anchyra Partners bought 42 CME Group shares in Q3 2026, an estimated $11.1K.
  • CME Group made up 0.27% of Anchyra Partners's portfolio in Q3 2026, its #67 holding.
  • Anchyra Partners first reported a position in CME Group in Q4 2025 and has held it in 4 quarters since.
  • Anchyra Partners's CME Group position peaked at $1.49M in Q1 2026.
  • 1,289 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Anchyra Partners's 13F filing for Q3 2026, filed 13 Oct 2026.